Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-22
1994-01-04
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514321, 514326, 546157, 546158, 546198, 546209, A61K 3147, C07D21520
Patent
active
052760405
ABSTRACT:
Certain 1-substituted 4-(1,2-benzisoxazolyl)-piperidine compounds exhibit neuroleptic activity and are useful in the treatment of psychosis and anxiety.
REFERENCES:
patent: 4458076 (1984-07-01), Strupczewski
patent: 4558060 (1985-12-01), Caignard et al.
patent: 4619932 (1986-10-01), Banno
patent: 4801595 (1989-01-01), Archibald
patent: 4831031 (1989-05-01), Lowe et al.
Strupczewski et al., J. Med. Chem., 1985, vol. 28, No. 6, pp. 761-769.
Leysen et al., J. Pharm. Exp. Ther., 247, No. 2, pp. 661-670, 1988.
Janssen et al., J. Pharm. Exp. Ther., 244, No. 2, pp. 685-693, 1988.
Benson Gregg C.
Chang Celia
Ivy C. Warren
Lumb J. Trevor
Pfizer Inc.
LandOfFree
4-(1,2-benzisoxazolyl)piperidine antipsychotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307461